PANAVIR IN HERPETIC INFECTION-COMPLICATED RHEUMATOID ARTHRITIS
The use of new effective immunosuppressive agents in rheumatoid arthritis (RA) increases the risk of comorbid or recurrent chronic infections, including viral ones. Panavir is a promising agent in treating viral infection (there are positive changes in the articular syndrome and interferon status in 6 months and RA stabilization during a 3-year follow-up).